Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.56USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$5.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
131,471
52-wk High
$9.69
52-wk Low
$4.44

Chart for

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $306.66
Shares Outstanding(Mil.): 53.99
Dividend: --
Yield (%): --

Financials

  PIRS.OQ Industry Sector
P/E (TTM): -- 169.61 31.56
EPS (TTM): -0.17 -- --
ROI: -9.44 1.42 12.88
ROE: -26.25 0.52 15.04

BRIEF-Pieris Pharmaceuticals Reports Q1 Loss Per Share $0.17

* PIERIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 10 2018

Earnings vs. Estimates